Morosan en es it fr

Morosan Brand names, Morosan Analogs

Morosan Brand Names Mixture

  • No information avaliable

Morosan Chemical_Formula


Morosan RX_link

Morosan fda sheet

Morosan msds (material safety sheet)

Morosan MSDS

Morosan Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Morosan Molecular Weight

284.74 g/mol

Morosan Melting Point


Morosan H2O Solubility

Slightly soluble (50 mg/L)

Morosan State


Morosan LogP


Morosan Dosage Forms

Tablets; Injectable solution

Morosan Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Morosan Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Morosan Absorption

Essentially complete, with a bioavailability of 93%.

Morosan side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Morosan Patient Information

Morosan Organisms Affected

Humans and other mammals